surmount-4 tirzepatide withdrawal weight regain for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Rebound Weight Gain After Stopping

Niacinamide supports NAD+ production and may improve insulin sensitivity further

Type 2 diabetes was identified in 3.4% of the group

The tirzepatide weight loss timeline typically shows measurable results within the first four to eight weeks, with the most dramatic changes occurring between months three and six as doses titrate upward

Tirzepatide may be helpful for some patients who are dealing with weight gain, insulin resistance, blood sugar concerns, or weight-related cardiovascular risk factors

Standard semaglutide The standard formulation contains only semaglutide as the active ingredient, with appropriate excipients for stability and sterility

The medication neither increased nor decreased UTI risk in any meaningful way